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Abstract
Methylotrophic Bacteria use one-carbon (C1) compounds as their carbon source.
They have been known to be associated to the human body for almost 20 years as
part of the normal flora and were identified as pathogens in the early 1990s in
end-stage HIV patients and chemotherapy patients. In this chapter, I look at C1
compounds in the human body and exposure from the environment and then
consider Methylobacterium spp. and Methylorubrum spp. in terms of infections
and its role in breast and bowel cancers,Methylococcus capsulatus and its role in
inflammatory bowel disease, and Brevibacterium casei and Hyphomicrobium
sulfonivorans as part of the normal human flora. I also consider the abundance
of methylotrophs from the Actinobacteria being identified in human studies
and the potential bias of the ionic strength of culture media and the needs for
future work. Within the scope of future work, I consider the need for the urgent
assessment of the pathogenic, oncogenic, mutagenic, and teratogenic potential of
Methylobacterium spp. and Methylorubrum spp. and the need to handle them at
higher containment levels until more data are available.
1 Introduction
The methylotrophs are a functional guild of the Bacteria that can grow on organic
one-carbon (C1) compounds as their sole source of carbon and energy. C1 com-
pounds do not contain carbon-carbon bonds, and thus every carbon-carbon bond
must be made de novo. Historically, methylotrophy was considered to be a restricted
and specialist metabolic mode that was only found in distinct taxonomic groups, but
in the last decade (e.g., Boden et al. 2008), the range of “generalist” organisms
displaying methylotrophic growth has increased. That said, on examination of
any recent taxonomy articles of generalist heterotrophs being isolated, the reader
will note a paucity of C1 compounds on the list of substrates examined – thus
we probably have an underestimation of the diversity of methylotrophic organisms.
The full gamut C1 compounds that occur in Nature or have been synthesized is
vast, and not all of them have been examined for growth by the Bacteria – while
the following list is exhaustive, it is no doubt incomplete: methane, methanol
(MeOH), dimethyl ether (DME), formaldehyde, formate, methanethiol (MeSH),
methaneselenol (MeSeH), methanetellurol (MeTeH), thioformaldehyde, dimethyl
sulfide (DMS), dimethyl sulfoxide (DMSO), dimethyl sulfone (DMSO2), dimethyl
disulfide (DMDS), dimethyl trisulfide (DMTS), dimethyl tetrasulfide (DMQS),
methanesulfonate (MSA), hydroxymethanesulfinate (Rongalite), monomethylamine
(MMA), dimethylamine (DMA), trimethylamine (TMA), trimethylamine N-oxide
(TMAO), methyl chloride, methyl bromide, methyl fluoride, formamide, N,N-
dimethylformamide, cyanamide, methanimine, diazomethane, carbon tetrachloride,
carbon tetrabromide, carbon tetraiodide, iodoform, bromoform, chloroform,
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fluoroform, methylene fluoride, methylene chloride, methylene bromide, methylene
iodide, various mixed halomethanes (e.g., dichlorodifluoromethane), methane-
sulfonyl chloride, hexamethylphosphoramide (HMPA), 1,3,5-trinitro-1,3,5-tri-
azinane (RDX or hexogen), N,N0-bis-(1H-tetrazol-5-yl)-hydrazine (HBT), 1,3,5,7-
tetranitro-1,3,5,7-tetrazocane (HMX or octogen), 2,4,6-trichloro-1,3,5-triazine
(cyanuric chloride or TCT), 6-chloro-N,N-dimethyl-1,3,5-triazine-2,4-diamine,
1,3,5-triazine-2,4,6-triamine (melamine), 1,3,5,-triazine-2,4,6-triol (sym-tri-
azinetriol), 1,3,5-triazine-2,4,6-trione (sym-triazinetrione), melamine-cyanurate
(1:1 mix of melamine and sym-triazinetrione), 2-cyanoguanidine (DCD), isocyanic
acid (carbamide), 1,3,5-triazine (vedita), 1,3,5-trioxane (trioxin), 1,3,5-trithiane
(thioform), 1,3-diazetidine, 1H-tetrazole, and 1,3,5-trithiane-1,1,3,3,5,5-hexaoxide.
Methyl iodide hydrolyzes spontaneously in water, as does methyl formate; thus these
probably do not contribute directly to methylotrophic growth. Thioformaldehyde
trimerizes into 1,3,5-trithiane spontaneously, and thus the former is probably not a
growth substrate itself. Phosgene, urea, carbonyl sulfide, and carbon disulfide are
also one-carbon compounds but are inorganic or are metabolized via carbon dioxide;
thus while they support growth, it is by autotrophs (e.g., Thiobacillus thioparus).
While not all of the C1 compounds listed above are found in Nature, their use as
building blocks in organic chemistry, solvents, explosives, plastics, pesticides, etc.,
results in their exposure to humans and to the environment. Some are also formed
within the human body from the breakdown of medications or poisons – such as
those based on 1H-tetrazole.
Methanotrophs are subset of methylotrophs that can grow on methane as a sole
carbon source – for some reason this metabolic trait is relatively restricted – but
methanotrophs range from being very restricted, apparently “only” growing on
methane, methanol, and sometimes MMA (but they have seldom been tested on a
truly wide range of substrates), to more generalist methanotrophs that grow on fatty
acids and intermediates of Krebs’ cycle.
The diversity of methylotrophs and methanotrophs has now been shown
to include a diverse range of genera, including members of the classes Alphapro-
teobacteria (e.g., Paracoccus, Methylosinus, Methylobacterium, Methylorubrum,
Xanthobacter), Betaproteobacteria (e.g., Methylophilus), Gammaproteobacteria
(e.g., Methylococcus, Crenothrix, Klebsiella, Pseudomonas, Sphingomonas),
Actinobacteria (e.g., Leifsonia,Mycobacterium, Gordonia, Rhodococcus), and clas-
sis incertae sedis in the phylum “Verrucomicrobia” (Candidatus Methylaci-
diphilum). In light of this, the potential for human-associated methylotroph
diversity to be much higher than previously considered is vast. It is worth noting
that the catabolism of the full range of one-carbon compounds is not fully under-
stood – many enzymes have not been purified and pathways are only putative – this
makes predictions of methylotrophic potential from human- or animal-associated
metagenomic datasets very difficult even in 2018, and considerable biochemical and
physiological studies are needed to understand the full gamut of methylotrophic
catabolism.
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2 C1 Compounds and the Human Body
The human body produces C1 compounds directly or as a consequence of the action
of normal microbial flora or pathogenic flora. Some genetic pathologies lead to an
increase in the production of C1 compounds. Additionally, topical application of
some C1 compounds in the form of “dietary supplements” or “alternative medicines”
(e.g., DMSO, DMSO2) occurs, as well as occupational exposure to C1 compounds
from the diet and from exposure to, e.g., chemicals by laboratory researchers.
While not all C1 compounds are odorous, many are foul-smelling and can be
detected at low levels, and thus have significant interest in terms of hygiene and the
cosmetics industry, which has led to a significant number of studies determining
various C1 compounds in body fluids, etc. The odor thresholds for C1 compounds
include (ppb by volume) DMS (3.0), DMDS (2.2), MeSH (0.07), MMA (35.0),
DMA (33.0), and TMA (0.032). For comparison (ppb by volume), hydrogen sulfide
(0.5), acetic acid (6.0), and butyric acid (0.19) are in similar orders of magnitude
(data from those curated by Wood and Kelly (2010) and Leonardos et al. (1969)).
2.1 Exogenous Exposure of the Human Body to C1 Compounds
In this section I have outlined some of the major routes by which the human body
can be exposed to exogenous C1 compounds or from consumption of precursors
such as pectin. It is not intended to be exhaustive but to give the reader a flavor of the
myriad routes to exposure.
2.1.1 C1 Exposure from the Diet
Many foods are known to contain C1 compounds, including TMA and TMAO in
fish and seafoods (the former produced from the latter by bacterial action, Bystedt
et al. (1959)) and DMS in Allium spp. L. (garlic, leek, onions, etc., Amiri (2007)
and Lawson et al. (1991)), Brassica spp. L. (cabbage, cauliflower, turnip, etc.,
Engel et al. (2002)), Solanum lycopersicum L. (tomato, Williams (1973)), Camellia
sinensis L. (tea, Smet et al. (1998)), Zea mays var. rugosa L. (sweetcorn, Bills
and Keenan (1968)), and Tuber spp. P.Micheli ex F.H.Wigg (truffles, Bellesia
et al. (1996) and Talou et al. (1990)). Methanol is produced from pectin (a hetero-
polysaccharide from plant cell walls and used as a gelling agent in jams, etc. – found
at particularly high concentrations in citrus peels, carrots, apples, and apricots)
breakdown in the gut at a rate of about 10–20 mmol per day (Lindinger et al.
1997) and is also taken up from alcoholic drinks – for example, a 50 mL measure
of brandy contains 2.5 mmol methanol (Lindinger et al. 1997).
2.1.2 C1 Exposure from “Dietary Supplements” and “Alternative
Medicines”
Two C1 sulfur compounds have become marketed as “dietary supplements”
(DMSO2) or “alternative medicines” (DMSO) in the last 20 years. The former is
sold as “methylsulfonylmethane” or MSM and is produced from waste from the
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Kraft paper process, as is DMSO, which is sold as an embrocation for use on stiff
joints, etc. Thus far, peer-reviewed clinical trials have shown minor beneficial
effect in some conditions (Usha and Naidu 2004), and in vitro studies have shown
antioxidant potential in DMSO2. It has been shown as safe for consumption of
>2.5 g per day with no ill effects. DMSO2-containing products currently marketed
include toothpastes, mouthwashes, shampoos, etc., all of which could have impli-
cations for perturbing the methylotrophic body flora. It is worth noting that sports
supplements containing choline are converted to TMA in the gut, and thus can be an
indirect source of TMA from such products.
2.1.3 C1 Exposure from the Environment and Occupational Exposure
Formate (as formic acid) is produced by ants of the genus Formica L. (wood ants,
Hoffman (2010)) and in the stinging hairs of Urtica dioica L. (the stinging nettle,
Klaessen (2013)). It is also produced from soils in deciduous forests (Sanhueza and
Andreae 1991) and probably from most soils, as is methane. Methylated amines and
sulfur compounds are produced in various plants and in decaying animal tissue.
DMS, DMSO, and DSMO2 are abundant in marine environments, in both the water
and the atmosphere, as is MSA.
Occupational exposure is of course largely for individuals working in the labo-
ratory sciences, where MeSH, DMS, DMSO, etc., can readily be absorbed through
the skin (Ljunggren and Norberg (1948) and from the author’s own experience: 5 mL
of a 10 mM DMS solution [totaling 50 μmol DMS or 3.1 mg] spilt on the hand could
be tasted for 16–24 h and was detectable in the odor of urine for 48 h!). TMA and
DMA emitted during the making of solutions of their hydrochloride salts cling on
the hair and skin for several hours. Solvents such as dichloromethane and carbon
tetrachloride are used in the chemical industry and can be inhaled resulting in their
transfer to the bloodstream or can be exposed to the skin. DMS and DMSO are
produced in the Kraft paper process and workers can be exposed (Leach and Chung
1982). In addition to laboratory and chemical industry workers, there is exposure to
DMS and methane at significant concentrations in swine and fowl farm workers
(Kim et al. 2007; Tymczyna et al. 2007). In animal rendering plants, Maillard
reactions in slaughterhouse waste heated to >105 C for tallow extraction result in
production of high concentrations of DMS that workers may be exposed to (van
Langenhove et al. 1982). Formaldehyde is used in embalming in mortuaries and in
the preservation of medical and zoological specimens in spirit collections, and so
occupational exposure through these routes is likely even with extraction systems.
2.2 Endogenous Exposure of the Human Body to C1 Compounds
Per Sect. 2.1, in this section I have outlined some of the major routes by which the
human body can be exposed to endogenous C1 compounds. Per my comments on
Sect. 2.1, it is not intended to be exhaustive.
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2.2.1 Oral Cavity
The odor of the human oral cavity changes with diet, medication, sexual intercourse,
and age. Oral malodor (halitosis) typically results from the production of DMS,
MeSH, carbon disulfide, MMA, DMA, TMA, and other volatiles (including meth-
anol and some methane), particularly from Bacteria located in the periodontal
pockets and on the rear of the tongue, as well as in the tonsillar crypts (Tonzetich
1973; Turner et al. 2006). Methylated selenium species (MeSeH and dimethyl-
selenide) may potentially be present in the oral odor profile of persons consuming
high-selenium diets or taking “selenium yeast” as a dietary supplement, but the
examination of methylated selenium and tellurium species in the human body thus
far has not been undertaken.
2.2.2 Skin
Human skin odor again, like that of the mouth, is subject to change and can contain
methylated amines and methylated sulfur species. It also varies across the body, with
those of the axillae and inguinal regions being particularly distinctive and varied by
biological sex, age, hormone profile, hormone cycle position, sexual intercourse,
exercise, adrenaline levels, medication, and diet. Full details of the odor of the skin
and hair are given in Wood and Kelly (2010) in a previous edition of this handbook.
Bromhidrosis (offensive body odor) can be caused by overgrowth of
Corynebacterium spp. and Micrococcus spp. The feet are also a cause of malodor,
and, like all body odor, this is largely mediated by clothing (Callwewaert et al. 2014).
Various clinical conditions are associated with altered body or skin odor such as
phenylketonuria (mouse or musty odor) or 2-oxoglutarate dehydrogenase complex
deficiency (maple syrup or caramel odor). Some of these conditions result in C1
compound production such as hypermethioninemia or type I tyrosinemia (carbon
disulfide and/or MeSH) and trimethylaminuria, which results in the inability of the
body to oxidize TMA into TMAO, resulting in TMA secretion and a strong odor that
may be fish-like or may just be unpleasant. This is present across the whole body,
including the mouth and urine, but the skin is the largest source (Mitchell and
Smith 2001). Similar effects are observed in dimethylglycinuria. The impacts of
trimethylaminuria and dimethylglycinuria have been discussed by Wood et al.
(2010) in a previous edition of this handbook. Gangrene and skin ulcers emit strong
odors containing methylated amines, DMS, etc., also, but this has not been investi-
gated in detail with respect to C1 compounds – DMTS has been found in some
cancer-associated wounds (Shirasu et al. 2009). While not odorous, DMSO2 can be
detected on the backs but not the arms of humans (Gallagher et al. 2008), which is
interesting since DMSO2 is found in cerebrospinal fluid, particularly in the spine
(Engelke et al. 2005).
2.2.3 Genitalia
The odor of the healthy female genital tract is dominated by fatty acids, which
increases during arousal and following sexual intercourse. The odor of TMA may be
present post-intercourse or after ovulation owing to bacterial activity, but is very
strong during bacterial vaginosis (Wood et al. 2010) and sexually transmitted
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infections (Preti et al. 1978). TMA is not present in the odor profile of most healthy
vaginae, pace immediately following menstruation in some individuals, as men-
tioned above (Wolrath et al. 2001). The odor profile of the neovagina of trans women
is lower and subject to less discharge, and the flora largely resembles those of the
anal canal or bacterial vaginosis flora (Weyers et al. 2009). Penile skin flora,
particularly in uncircumcised males, produces TMA around the base of the glans,
particularly if copious smegma is evident (Cold and Taylor 1999). There is a paucity
of data on the odor of the neopenis in trans men.
2.2.4 Gastrointestinal Tract
The large intestine produces methane and a range of sulfur-containing gases such
as DMS, MeSH, and hydrogen sulfide (Suarez et al. 1999). This varies with diet
(Florin et al. 1991), with sulfur-rich and selenium-rich foods contributing MeSH,
DMS, DMTS and DMDS, or MeSeH and dimethylselenol, respectively (Moore et al.
1987). The processes of their formation by anaerobic Bacteria and Archaea acting
ultimately on cysteine, cystine, and methionine from digested proteins are analogous
to the putrefaction of proteins in decaying animal tissue, in landfill, or in anoxic soils,
which are outlined in Schäfer et al. (2010).
3 Methylotrophs Known to Be Associated
with the Human Body
The first reports of methylotrophs associated with the human body as part of the
normal flora were published by Dr. Ann PWood’s group (formerly of King’s College
London, UK) in the early part of this century and made use of both isolation and
molecular methods. Since this pioneering work almost 20 years ago, there have been
a considerable number of reports of human-associated methylotrophic Bacteria. As
I discuss herein, there has been a considerable volume of work as a direct result
of these studies at King’s College London, which have now begun to lead to an
understanding of the role of methylotrophs and methanotrophs from the normal flora
in hollow organ and breast cancers and in various pathologies – it is of no doubt that
those early studies regarding “Methylobacterium podarium” (now Methylorubrum
podarium) will, in the fullness of time, directly lead to work that save lives.
Isolation of strains for characterization has been a core part of microbiology for
over 100 years, and, while it is not as fashionable as metagenomics, etc., it is entirely
necessary for obtaining evidence on enzyme biochemistry, evolution, etc., and some
of the human-associated methylotrophs in pure culture are very well characterized,
but we do not have genome sequences yet for anyMethylorubrum podarium strains,
for example. It is worth noting that there are a lot of studies in the last decade that
produce a large number of isolates without any identification or characterization
(e.g., feet and oral isolates from Waturangi et al. (2011) that were isolated on 24 mM
methanol), and while these libraries of organisms might be very useful to the
community, it is really critical that proper identifications are made and deposits
into international service collections are made before strains are lost.
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In this section I have covered three particularly interesting taxa in some detail
and summarized the remainder of the work done, including some recent molecular
ecological studies that have detected methylotroph presence.
4 Methylobacterium and Methylorubrum spp.
Methylobacterium spp. (Mbt.) are the archetypal “pink-pigmented facultative
methylotroph” (PPFM) that one can easily isolate in the classical experiment of
placing leaves on mineral salts agar for a few hours and then removing the leaves and
incubating in an atmosphere of methanol vapor – they appear as salmon, pink, or
orange colonies that fit the shape of the original leaf. Recently, Green and Ardley
(2018) have proposed the reclassification of a large group of Methylobacterium
spp. to Methylorubrum (Mrb.), a newly created genus (as shown in Fig. 1).
Members of these genera are found in a myriad of environments including plants,
bryophytes, and soils to more nutrient-poor environments such as drinking
water (Methylobacterium adhaesivum (Gallego et al. 2006), Methylobacterium
hispanicum and Methylobacterium aquaticum (Gallego et al. 2005a), and
Methylobacterium isbiliense (Gallego et al. 2005b)), the air (Methylobacterium
aerolatum and Methylobacterium iners, Weon et al. 2008), and fermented sea-
foods (Methylobacterium jeotgali Aslam et al. 2007) – all potential routes through
which the human body could make contact and become colonized – but it is
interesting to note that these taxa are not among those known to cause infection.
Methylobacterium spp. andMethylorubrum spp. are found in many bathrooms as
pink or orange biofilms growing on tiling grout or on shower curtains and taking up
C1 compounds found near to toilets. It has recently been proposed that the presence
of Methylobacterium spp. and Methylorubrum spp. in bathroom biofilms corre-
sponds to a lack of potentially pathogenic Mycobacterium spp. in said biofilms
and that this could be a useful indicator (Falkinham et al. 2016).
4.1 Role in Normal Human Flora
From the feet of healthy volunteers, various strains of Methylorubrum podarium
(basonym, Methylobacterium podarium) have been isolated. The type strain
(FM4T = DSM 15083T = ATCC BAA-547T) was isolated from a toe cleft. The
cleft was swabbed with a sterile cotton swap which was used to inoculate an
enrichment culture using 20 mM MMA as the sole carbon source, from which the
isolate was obtained on MMA agar. This pink-pigmented species grows on MMA,
DMA, TMA, methanol, MeSH, DMS, DMSO, DMSO2, formate, and a wide range
of organic acids, alcohols, and sugars (Anesti et al. 2004).
Methylorubrum zatmanii (basonym, Methylobacterium zatmanii) PI-UM was
isolated from the mouth of a patient with significant dental caries and periodontal
disease by enrichment culture on 12 mM methanol (Carvajal et al. 2011).
Methylorubrum rhodesianum (basonym, Methylobacterium rhodesianum) was
isolated from the front of the human scalp (Uy et al. 2013), and a further
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Methylobacterium longum 440T (FN868949)
Methylobacterium phyllostachyos BL47T (EU912444)
Methylobacterium tardum RB677T (AB252208)
Methylobacterium radiotolerans JCM 2831T (MTBJCMA04)
Methylobacterium fujisawaense DSM 5686T (AJ250801)
Methylobacterium oryzae CBMB20T (AY683045)
Methylobacterium phyllosphaerae CBMB27T (EF126746)
Methylobacterium pseudosasicola BL36T (EU912439)
Methylobacterium brachiatum B0021T (AB175649)
Methylobacterium mesophilicum DSM 1708T (AB175636)
Methylobacterium gregans 002-074T (AB252200)
Methylobacterium hispanicum GP34T (AJ635304)
Methylobacterium trifolii TA73T (FR847848)
Methylobacterium dankookense SW08-7T (FJ155589)
Methylobacterium cerastii C15T (FR733885)
Methylobacterium jeotgali S2R03-9T (DQ471331)
Methylobacterium bullatum F3.2T (FJ268657)
Methylobacterium marchantiae JT1T (FJ157976)
Methylobacterium komagatae 002-079T (AB252201)
Methylobacterium aerolatum 5413S-11T (EF174498)
Methylobacterium persicinum 002-165T (AB252202)
Methylobacterium brachythecii 99bT (AB703239)
Methylobacterium gnaphalii 23eT (AB627071)
Methylobacterium haplocladii 87eT (AB698691)
Methylobacterium thuringiense C34T (FR847847)
Methylobacterium organophilum ATCC 27886T (AB175638)
Methylobacterium aquaticum GR16T (AJ635303)
Methylobacterium tarhaniae N4211T (JQ864432)
Methylobacterium platani PMB02T (EF426729)
Methylobacterium variabile GR3T (AJ851087)
Methylobacterium isbiliense AR24T (AJ888239)
Methylobacterium nodulans ORS 2060T (AF220763)
Methylorubrum salsuginis MRT (EF015478)
Methylorubrum rhodinum DSM 2163T (AB175644)
Methylorubrum suomiense NCIMB 13778T (AB175645)
Methylorubrum aminovorans JCM 8240T (AB175629)
Methylorubrum extorquens DSM 6343 (AB175631)
Methylorubrum extorquens IAM 12631T (AB175632)
Methylorubrum extorquens AM1 (MexAM1_META1p16S5)
Methylorubrum extorquens CM4 (CP001298)
Methylorubrum zatmanii DSM 5688T (AB175647)
Methylorubrum populi BJ001T (CP001029)
Methylorubrum thiocyanatum ALL/SCN-PT (MAU58018)
Methylorubrum podarium FM4T (AF514774)
Methylorubrum lusitanum NCIMB 13779T (AB175635)
Methylorubrum rhodesianum DSM 5687T (AB175642)
Methylobacterium iners 5317S-33T (EF174497)
Methylobacterium adhaesivum AR27T (AM040156)
Methylobacterium goesingense iEII3T (AY364020)
Methylobacterium gossipiicola Gh-105T (EU912445)
Methylobacterium oxalidis 35aT (AB607860)
Methylobacterium soli YIM 48816T (EU860984)
Methylosinus spp.
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99
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
Fig. 1 Phylogenetic tree on the basis of the 16S rRNA (rrs) gene, showing the positions
of Methylobacterium spp. and Methylorubrum spp., using the sequences from Methylosinus spp.
as the outgroup. Nucleotide sequences were aligned using MUSCLE (Edgar 2004) without use of
any presets for speed that reduce accuracy. Aligned sequences were tested for best fit to models on
the basis of the Bayesian information coefficient (BIC) in MEGA 7.0.26 (Kumar et al. 2016) and the
trees reconstructed accordingly, using the Tamura-Nei model (Tamura and Nei 1993) with a discreet
gamma distribution to model rate differences across sites (gamma parameter, 0.1439) and allowance
for some sites to be evolutionarily invariable (67.04% of sites). The tree shown is the optimal tree
with the highest log-likelihood after 5,000 replications (18,617.15), with numbers at nodes
indicating the percentage of 5,000 bootstrap replications in which the topology was preserved
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Methylobacterium or Methylorubrum sp. was isolated from the nasal vestibule
(Uy et al. 2013). A strain of Methylobacterium radiotolerans was isolated from
the naval (David and Diongzon 2013) – some properties of this strain are reviewed
in Carvajal and Galvez (2015). Methylorubrum thiocyanatum (basonym,
Methylobacterium thiocyanatum) and M. radiotolerans strains have been isolated
from the human mouth (Anesti et al. 2005; Hung et al. 2011), as well as strains from
the urinary tract (Lee et al. 2004). Lauder et al. (2016) detectedMethylobacterium or
Methylorubrum spp. on placental samples.
4.2 Role as Human Pathogens
In spite of Methylobacterium spp. being “workhorse” organisms in laboratories
worldwide for many decades, they have recently been identified as opportunistic
pathogens, before we fully understood that they were part of the normal flora in the
seminal work of Wood, though we did have an understanding of their prevalence
in human-associated environments, viz., their presence as 20% of the cultivable flora
in dental unit waterlines (Barbeau et al. 1996). The first reports in the 1980s were
of Methylobacterium mesophilicum in nosocomial infections (Gilardi and Faur
1984; Gilchrist et al. 1986; Rutherford et al. 1988; Smith et al. 1985) and later
came reports of a patient given contaminated bone marrow (Brown et al. 1996) and
in HIV patients with bacteremia (Truant et al. 1998). It is interesting to note that the
type strain Mbt. mesophilicum ATCC 29983T was isolated from a leaf (Austin and
Goodfellow 1979). The ability of this genus to form robust biofilms no doubt
contributes to its prevalence in the environment and its pathogenicity (Kovaleva
et al. 2014). Methylobacterium radiotolerans, Methylorubrum thiocyanatum,
Methylorubrum aminovorans (basonym, Methylobacterium aminovorans), and
Methylorubrum lusitanum strains have all been isolated from patients with
hospital-acquired bacteremia (Lai et al. 2011). It is worth noting thatMrb. lusitanium
is likely a heterotypic synonym of Mrb. rhodesianum (Kato et al. 2005).
Methylobacterium mesophilicum was included in the Vaginal Flora Microbial
DNA qPCR Array (Qiagen 2013), indicating that the importance of this opportu-
nistic pathogen and accurate diagnosis thereof has been accepted. Molecular

Fig. 1 (continued) (values <70% omitted for clarity). All positions at which there was less than
95% coverage were omitted from the final analysis, in which 1,345 nt was used. Branch lengths are
to scale and indicate the number of substitutions per site – bar represents 0.05 substitutions per site.
Accession numbers are given in parentheses and refer to the GenBank database, unless they contain
an underscore (“_”), which designates that they are from the Integrated Microbial Genomes and
Metagenomes (IMG/M) database. Type strains are indicated by a superscript “T” – multiple strains
ofMbt. extorquens are included, viz., the “workhorse” strain AM1 and the various strains that grow
on methyl halides, and were reclassified into this species. Colored dots indicate cyan, skin isolate;
green, mouth isolate; orange, vaginal isolate; violet, opportunistic pathogen; red, associated with
cancer
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ecological methods have identified methylotrophs in the vagina during bacterial
vaginosis (Wood et al. 2010) and in sex workers (Schellenberg et al. 2011). Tran-
scripts from Methylobacterium spp. and Methylorubrum spp. were found albeit in
relatively small numbers in both women with bacterial vaginosis about to undergo
treatment with 200 mg lactoferrin applied per vagina, and in women after treatment
with 100 mg lactoferrin, which restored this genus that was not easily detected in the
pretreatment state (Pino et al. 2017).
4.3 Potential Roles in Breast Cancer
Recently several links between Methylobacterium spp. or Methylorubrum spp. and
breast cancers have been published. A decreased level of these genera in breast tissue
and breast cancer was reported (Wang et al. 2017), suggesting that some compound
they would typically degrade on/in the breast could reach the blood at higher levels
when the organism is present in lower numbers, with potentially carcinogenic effects.
It is hard to determine what that compound is since it may not be a C1 compound,
owing to their facultative nature, but it is entirely plausible that, e.g., dimethyl sulfone
taken orally could act as a probiotic, encouraging growth of Methylobacterium spp.
or, more likely, Methylorubrum spp. on the skin and, potentially, in some way
reducing cancer risk. That said, theWang et al. (2017) study is one study: significantly
more work needs to be undertaken before we can be certain of any role of these genera
in cancer prevention, and given we knowMethylobacterium spp. andMethylorubrum
spp. are pathogenic, any proposed therapies need to be implemented with great
caution and not used in immunocompromised individuals.
While the above Wang et al. (2017) study suggests Methylobacterium being
depleting in number may be associated to breast cancer, Xuan et al. (2016) found
the opposite. In their study, Methylobacterium radiotolerans was highly enriched
in breast tissue, along with Sphingomonas yanoikuyae (we know that some
Sphingomonas spp. grow methylotrophically, cf. Boden et al. 2008). Yadzi et al.
(2016) evaluated the presence of these two species in sentinel lymph nodes removed
at mastectomy from breast cancer patients, finding their presence to bemuch higher in
nodes adjacent to stage 1 tumors than in controls (e.g., 97% of stage 1 tumor samples
contained Mbt. radiotolerans or S. yanoikuyae DNA), and in stage 2 and stage
3 tumors, the levels of these two organisms were even higher.
The type strain of Methylobacterium radiotolerans (ATCC 27329T = NCIMB
10815T) was isolated from rice grains and tolerates 0.18 Mrad (= 1.8 kGy) doses of
gamma radiation (Ito and Iizuka 1971) – if indeed this organism is involved in cancer
causation, this could have implications in gamma radiotherapy, where local doses are
in the region of 0.002 kGy during breast cancer treatment (Hong et al. 2018), and
would not kill the organism. The radiation tolerance mechanisms are probably an
evolutionary adaptation to dehydration, in common with other radiation tolerant
organisms and in keeping with its source of isolation in dehydrated rice (Musilova
et al. 2015). Interestingly, the type strain of S. yanoikuyae (ATCC 51230T = DSM
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7462T) was originally isolated from an unspecified clinical specimen, suggesting it
may be prevalent on the human body (Yabuuchi et al. 1990).
Of course it is obvious that breast tumors – like many cancers – often become
necrotic and emit MMA, DMA, TMA, DMS, MeSH, DMDS, DMTS, and other
pungent volatiles (Warnke et al. 2003; Shirasu et al. 2009); the Methylobacterium
spp. present may simply be “mopping up” these compounds and may have abso-
lutely no role in cancer.
4.4 Potential Roles of Methylobacterium spp. and Methylorubrum
spp. in Other Cancers
Methylobacterium spp. orMethylorubrum spp. were found to be enriched in number
in cancerous tissue of colorectal cancer patients versus controls (Chen et al. 2012)
and in gastric cancer patients – specifically Mbt. adhaesivum in the latter case
(Castaño-Rodriguez et al. 2017). It is worth noting that the type strain (CCM
7305T = CECT 7069T) of Mbt. adhaesivum has been isolated from drinking water
supplies (Gallego et al. 2006); thus the route of exposure to the stomach is easy to
determine.
4.5 Perspectives
It is interesting to note that the pathogenic Methylobacterium spp. and
Methylorubrum spp. are seemingly limited to a relatively small number of species.
Figure 1 shows a maximum likelihood tree based on the 16S rRNA (rrs) gene
of Methylobacterium spp. and Methylorubrum spp. using Methylosinus spp. as
the outgroup. Full details of the tree algorithms, etc., are given in the legend to
Fig. 1. It can be seen from Fig. 1 that the cancer-associated organisms are found in
both genera but that the nonpathogenic skin, vagina, and mouth isolates are mostly
relatively closely related – though some of these are agents of infection – and are
members of Methylorubrum.
While findings on Methylobacterium and Methylorubrum and their associations
with human cancers are interesting, there is, however, a major caveat that must
always be upheld: findings from molecular-based studies probably need to be
reinforced with isolation-based work. This is owing to the presence of contaminating
biomass/DNA from these genera – and from other methylotrophs – being common-
place in DNA and RNA extraction and purification kits, as well as in other molecular
ecology sundry items. Salter et al. (2014) gives a good overview of the relevant
literature on these kits. Contamination of so-called “ultrapure” (filtered) water
supplies with the same organisms is also well understood with the evidence base
going back over 25 years now (e.g., Kulakov et al. 2002; McFeters et al. 1993) –
obviously glass-distilled water that has then been autoclaved may provide a suitable
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alternative as DNA/RNAwould not be anticipated to distill over! It is critical that all
molecular-only demonstrations of the presence of these organisms in the human
body, particularly where their presence is then correlated with some pathology or
other, are validated to show the presence of viable and/or isolable cells.
It is clear that a proper appraisal of (1) infectious agent status and (2) oncogenesis
is needed in Methylobacterium spp. and Methylorubrum spp. as a priority – these
species are handled worldwide in research laboratories and teaching laboratories,
occur in domestic bathrooms, are found on the skin of probably most humans on the
planet, and are potentially causative agents of infectious disease and cancer, but are
not currently handled as such.
5 Hyphomicrobium sulfonivorans
Hyphomicrobium sulfonivorans S1T (=ATCC BAA-113T = DSM 13863T) was
originally isolated from garden soil using DMSO2 as the sole carbon source; it
also grows on other C1 sulfur compounds and amines and is very well characterized
(Borodina et al. 2000, 2002; Boden et al. 2011). Hyphomicrobium spp. are pro-
sthecate organisms that have holdfasts and form rosettes and flocks in culture
and can adhere strongly to surfaces in biofilms. They are well known to grow in
low-nutrient environments, and workers in most C1 research laboratories will be
familiar with Hyphomicrobium spp. being found in the distilled water aspirator!
H. sulfonivorans CT and DTg were isolated from the teeth and tongues of healthy
volunteers (Anesti et al. 2005) using 2 mM DMS as the sole carbon source. These
strains can grow on DMS, DMSO, DMSO2, MeSH, methanol, MMA, TMA,
formaldehyde, and formate but not DMA. They also grow on a range of organic
acids and sugars – it is thus difficult to know if they are actually “methylotrophing”
when in the human mouth, though in all likelihood, they are probably assimilating
a whole range of carbon sources at the same time when growing in situ versus
our in vitro cultures on single substrates.
6 Brevibacterium casei
Brevibacterium casei 3Tg and 3S(a) were isolated from dental hospital patients with
periodontal disease using 2 mM DMS as the sole carbon source (Anesti et al. 2005).
They grow on DMS, DMSO, MeSH, methanol, MMA, TMA, and formate but
not DMA and grow on a range of organic acids, sugars, and complex media.
Brevibacterium is not considered a “classical” methylotrophic genus; however, the
first report was in Brevibacterium methylicum (Nešvera et al. 1991). Interestingly,
the type strain B. casei DSM 20657T will grow on methanol, MMA, MeSH, and
DMS (Anesti et al. 2005), demonstrating that methylotrophy is probably widespread
in this species, if not this genus. Hung et al. (2011) isolated Brevibacterium spp. from
the human mouth also.
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7 Immune Modulation by Methylococcus capsulatus
Methylococcus capsulatus (Mcc.) is probably the best studied obligate
methanotroph. The type strain TexasT was originally isolated from a sewer but
has not been studied in much depth – the Bath strain has become the international
workhorse methanotroph. It contains intracellular stacked membranes of the “type I”
variety (bundles of disc-shaped vesicles in the middle of the cytoplasm); the
dominant fatty acids are palmitic (C16:0) and palmitoleic (C16:1) acids. It uses 18-
methylene-ubiquinone-8 as the major respiratory quinone, which is rather unusual in
the Gammaproteobacteria but common in theMethylococcales. An excellent review
of Methylococcus capsulatus general physiology and metabolic potential is that of
Kelly et al. (2005).
While not a human isolate, freeze-dried, lysed methane-grown cells of the Bath
strain (=NCIMB 11132) of Methylococcus capsulatus (albeit incorrectly described
as a “soil bacterium” when it came from sulfidic groundwater!) have been shown to
prevent inflammatory bowel disease in mouse models (Indrelid et al. 2017) and
adhere to human dendritic cells, influencing their ability to produce cytokines,
activate T cells, etc. Previous work by Christoffersen et al. (2015) showed that
Mcc. capsulatus Bath reduced intestinal inflammation in animal models, and work
by Kleiveland et al. (2013) showed that Mcc. capsulatus Bath reduced ulcerative
colitis in animal models.
8 Other Human Isolates and Isolation Work Biases
In the oral work of Anesti et al. (2005), Micrococcus luteus and Variovorax
paradoxus strains were isolated on C1 compounds. Further oral work by Hung
et al. (2011) isolated Gordonia, Leifsonia, Microbacterium, Micrococcus,
Rhodococcus, Achromobacter, Klebsiella, Pseudomonas, and Ralstonia strains
on C1 compounds, growing variously on MSA, MMA, and DMSO2. All of these
organisms are canonically “atypical” methylotrophs, but it is worth noting that
the author has isolated DMA-using Mycobacterium fluoranthenivorans DSQ3
and Rhodococcus erythropolis DSQ4, TMA-using Pseudomonas mendocina, and
MMA-using Brevibacterium casei MSQ5 (Boden et al. 2008) from river sediment,
and there are many reports of Gram-positive methylotrophs.
These “noncanonical” methylotrophs are relatively easy to isolate, and it is worth
noting that the media used for the studies of Boden et al. (2008), Hung et al. (2011),
Borodina et al. (2000, 2002), and Anesti et al. (2004, 2005) were all using basal salts
of ionic strength 1.12 M (determined according to Debye and Hückel (1923) using
data from the above studies minus the carbon source) – this is a comparatively
very high ionic strength relative to media used for Methylobacterium spp. or
methanotrophs, for example, nitrate mineral salts (NMS) of Dalton and Whittenbury
(1976) have an ionic strength of 0.11 M (using data from Smith and Murrell 2011),
and “dilute” variations used for Methylocella spp. could be as low as 0.01 M. It is
possible that using higher ionic strength media in future work could reveal the
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diversity of Gram-positive methylotrophs (and potentially methanotrophs), but
similarly, use of lower ionic strength media in future human studies may help isolate
“canonical” methylotrophs and methanotrophs.
9 Research Needs
1. The urgent assessment of pathogenicity, oncogenesis, mutagenesis, and terato-
genesis in all Methylobacterium spp. and Methylorubrum spp. is held in the
international service collections and potentially the rest of the Methylobac-
teriaceae, if not all of the Rhizobiales. This is necessary to fully understand the
gamut of potential infections and cancers that these organisms are associated
with, and to aid current and future patients with Methylobacterium or
Methylorubrum infections and cancers but is also critical for the protection of
laboratory workers worldwide. In the meantime, I strongly recommend all
Methylobacterium and Methylorubrum spp. be treated as Containment Level
2 (CL2) organisms rather than their usual Containment Level 1 (CL1) handling
until we know more about the potential hazards and risks. It would seem prudent
to remove them from the teaching laboratory unless at CL2 level.
2. Reevaluation of molecular-only studies that associate Methylobacterium and
Methylorubrum spp. with human cancers, demonstrating the presence of viable
cells and ruling out kit/reagent contamination.
3. Reappraisal of methylotrophy in known human-associated Bacteria, particularly
Gram-positive organisms from the class Actinobacteria. Isolation with higher
ionic strength media may achieve this.
4. The normalization of workers assessing growth on methanol, MMA, etc., in all
new bacterial isolates to help see the true diversity of methylotrophy.
5. An appraisal of methylotrophs and methanotrophs in the anal canal and perianal
area since methane (and DMS, MeSH, etc.) and oxygen are present, and this
environment should support growth.
6. Greater understanding of the role of Methylobacterium and Methylorubrum in
breast cancer prevention – is it cause or effect? Does it only apply to the breast?
What happens in other cancers? Does DMSO2 consumption reduce the risk or
elevate of these types of cancer in model organisms?
Acknowledgments I thank Dr. Ann P Wood (formerly of King’s College London, UK) for
stimulating discussions on methylotrophy and human disease and Dr. Michael J Cox (Imperial
College London, UK) for insight on methylotrophic contamination of molecular studies. I also
thank Dr. Lee P Hutt (University of Plymouth, UK) for reading and commenting on the manuscript.
References
Amiri H (2007) Chemical composition and antibacterial activity of the essential oil of Allium
jesdianum Boiss. & Buhse from Iran. J Med Plants 6:39–44+65
Methanotrophy, Methylotrophy, the Human Body, and Disease 15
Anesti V, Vohra J, Goonetilleka S, McDonald IR, Sträubler B, Stackebrandt E, Kelly DP,
Wood AP (2004) Molecular detection and isolation of facultatively methylotrophy, including
Methylobacterium podarium sp. nov., from the human foot. Environ Microbiol 6:820–830
Anesti V, McDonald IR, Ramaswamy M, Wade WG, Kelly DP, Wood AP (2005) Isolation
and molecular detection of methylotrophic bacteria occurring in the human mouth. Environ
Microbiol 7:1227–1238
Aslam Z, Lee CS, Kim KH, Im WT, Ten LN, Lee ST (2007) Methylobacterium jeotgali sp. nov.,
a non-pigmented, facultatively methylotrophic bacterium isolated from jeotgal, a traditional
Korean fermented seafood. Int J Syst Evol Microbiol 57:566–571
Austin B, Goodfellow M (1979) Pseudomonas mesophilica, a new species of pink bacteria isolated
from leaf surfaces. Int J Syst Bacteriol 29:373–378
Barbeau J, Tanguay R, Faucher E, Avezard C, Trudel L, Côté L, Prévost A (1996) Multiparametric
analysis of waterline contamination in dental units. Appl Environ Microbiol 62:3954–3959
Bellesia F, Pinetti A, Bianchi A, Tirillini B (1996) Volatile compounds of the white truffle
(Tuber magnatum Pico) from Middle Italy. Flavour Fragr J 11:239–243
Bills DD, Keenan TW (1968) Dimethyl sulfide and its precursor in sweetcorn. J Agric Food Chem
16:643–645
Boden R, Thomas E, Savani P, Kelly DP, Wood AP (2008) Novel methylotrophic bacteria isolated
from the River Thames (London, UK). Environ Microbiol 10:3225–3236
Boden R, Borodina E, Wood AP, Kelly DP, Murrell JC, Schäfer H (2011) Purification and
characterization of dimethylsulfide monooxygenase from Hyphomicrobium sulfonivorans.
J Bacteriol 193:1250–1258
Borodina E, Kelly DP, Rainey FA, Ward-Rainey NL, Wood AP (2000) Dimethylsulfone as a
growth substrate for novel methylotrophic species of Hyphomicrobium and Arthrobacter.
Arch Microbiol 173:425–437
Borodina E, Kelly DP, Schumann P, Rainey FA, Ward-Rainey NL, Wood AP (2002) Enzymes
of dimethylsulfone metabolism and the phylogenetic characterization of the facultative
methylotrophs Arthrobacter sulfonivorans sp. nov., Arthrobacter methylotrophus sp. nov., and
Hyphomicrobium sulfonivorans sp. nov. Arch Microbiol 177:173–183
Brown MA, Green JN, Sandin RL, Heimenz JW, Sinnott JT (1996) Methylobacterium bacteremia
after infusion with contaminated autologous bone marrow. Clin Infect Dis 23:1191–1192
Bystedt J, Swenne L, Aas HW (1959) Determination of trimethylamine oxide in fish muscle. J Sci
Food Agric 10:301–304
Callwewaert C, De Maeseneire E, Kerckhof F-M, Verliefde A, van de Wiele T, Boon N (2014)
Microbial odour profile of polyester and cotton clothes after a fitness session. Appl Environ
Microbiol 80:6611–6619
Carvajal TM, Galvez JB (2015) Current research status on the biology of pink pigmented facultative
methylotrophic (PPFM) bacteria belonging to the genus Methylobacterium in the Philippines.
Philipp J Syst Biol 9
Carvajal TM, Tan RL, Lee AC (2011) Methylobacterium zatmanii, a pink pigmented facultative
methylotrophic (PPFM) bacterium isolated from the human oral cavity. Philipp J Syst Biol
5:1–9
Castaño-Rodriguez N, Goh K-L, Fock KM, Mitchell HM, Kaakoush NO (2017) Dysbiosis of the
microbiome in gastric carcinogenesis. Sci Rep 7:15957
Chen W, Liu F, Ling Z, Tong Z, Xiang C (2012) Human intestinal lumen and mucosa-associated
microbiota in patients with colorectal cancer. PLoS One 7:e39743
Christoffersen TE, Olsen Hult LT, Solberg H, Bakke A, Kuczkowska K, Huseby E, Jacobsen M,
Lea T, Kleiveland CR (2015) Effects of the non-commensal Methylococcus capsulatus Bath on
mammalian immune cells. Mol Immunol 66:107–116
Cold CJ, Taylor JR (1999) The prepuce. Br J Urol 83:34–44
Dalton H, Whittenbury R (1976) The acetylene reduction technique as an assay for nitrogenase
activity in the methane oxidizing bacterium Methylococcus capsulatus (Bath). Arch Microbiol
109:147–151
16 R. Boden
David AKS, Diongzon NEM (2013) Phenotypic and genotypic characterization of pink
pigmented facultative methylotrophic (PPFM) bacteria isolated from the human belly button.
Undergraduate thesis, De La Salle University, Manila
Debye P, Hückel E (1923) Zur Theorie der Elektrolyte. I. Gefrierpunktserniedrigung und verwandte
Erscheinungen. Phys Z 24:185–206
Edgar RC (2004) Multiple sequence alignment with high accuracy and high throughput. Nucleic
Acids Res 32:1792–1797
Engel E, Baty C, LeCorre D, Souchen I, Martin N (2002) Flavor-active compounds potentially
implicated in cooked cauliflower acceptance. J Agric Food Chem 50:6459–6467
Engelke UF, Tangerman A, Willemsen MA, Moskau D, Loss S, Mudd SH, Wevers RA (2005)
Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional
1H and two-dimensional 1H-13C NMR. NMR Biomed 18(5):331–336
Falkinham JO 3rd, Williams MD, Kwait R, Lande L (2016) Methylobacterium spp. as an indicator
for the presence or absence of Mycobacterium spp. Int J Mycobacteriol 5:240–243
Florin TG, Neale G, Gibson GR, Christi SU, Cummings JH (1991) Metabolism of dietary sulphate:
absorption and excretion in humans. Gut 32:766–773
Gallagher M, Wysocki CJ, Leyden JJ, Spielman AI, Sun X, Preti G (2008) Analyses of volatile
organic compounds from human skin. Br J Dermatol 159:780–791
Gallego V, García MT, Ventosa A (2005a) Methylobacterium hispanicum sp. nov. and
Methylobacterium aquaticum sp. nov., isolated from drinking water. Int J Syst Evol Microbiol
55:281–287
Gallego V, García MT, Ventosa A (2005b) Methylobacterium isbiliense sp. nov., isolated from the
drinking water system of Sevilla, Spain. Int J Syst Evol Microbiol 55:2333–2337
Gallego V, García MT, Ventosa A (2006) Methylobacterium adhaesivum sp. nov., a novel
methylotrophic bacterium isolated from drinking water. Int J Syst Evol Microbiol 56:339–342
Gilardi GL, Faur YC (1984) Pseudomonas mesophilica and an unnamed taxon, clinical isolates of
pink-pigmented oxidative bacteria. J Clin Microbiol 20:626–629
Gilchrist MJR, Kraft JA, Hammon JG, Connelly BL, Myers MG (1986) Detection of Pseudomonas
mesophilica as a source of nosocomial infections in a bone marrow transplant unit. J Clin
Microbiol 23:1052–1055
Green P, Ardley JK (2018) Review of the genusMethylobacterium and closely related organisms: a
proposal that some Methylobacterium species be reclassified into a new genus, Methylorubrum
gen. nov. Int J Syst Evol Microbiol 68:2727
Hoffman DR (2010) Ant venoms. Curr Opin Allergy Clin Immunol 10:342–346
Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosortez A,
Park HS, Soulos PR, Evans SB (2018) Radiation dose and cardiac cancer risk in breast cancer
treatment: an analysis of modern radiation therapy including community settings. Pract Radiat
Oncol. https://doi.org/10.1016/j.prro.2017.07.005
Hung W-L, Wade WG, Boden R, Kelly DP, Wood AP (2011) Facultative methylotrophs from the
human oral cavity and methylotrophy in strains of Gordonia, Leifsonia, and Microbacterium.
Arch Microbiol 193:407–417
Indrelid S, Kleiveland C, Holst R, Jacobsen M, Lea T (2017) The soil bacterium Methylococcus
capsulatus Bath interacts with human dendritic cells to modulate immune function. Front
Microbiol 8:230
Ito H, Iizuka H (1971) Taxonomic studies on a radio-resistant Pseudomonas. J Agric Biol Chem
35:1566–1571
Kato Y, Ashara M, Arai D, Goto K, Yokata A (2005) Reclassification of Methylobacterium
chloromethanicum and Methylobacterium dichloromethanicum as later subjective synonyms
of Methylobacterium extorquens and of Methylobacterium lusitanum as a later subjective
synonym of Methylobacterium rhodesianum. J Gen Appl Microbiol 51:287–299
Kelly DP, Anthony C, Murrell JC (2005) Insights into the obligate methanotroph Methylococcus
capsulatus. Trends Microbiol 13:195–198
Methanotrophy, Methylotrophy, the Human Body, and Disease 17
Kim KY, Ko HJ, Kim HT, Kim YS, Roh YM, Lee CM, Kim HS, Kim CN (2007) Sulfuric odorous
compounds emitted from pig-feeding operations. Atmos Environ 41:4811–4818
Klaessen C (2013) Casarett & Doull’s toxicology: the basic science of poisons, 8th edn.
McGraw Hill, New York
Kleiveland CR, Hult LT, Spetalen S, Kaldhusdal M, Christoffersen TE, Bengtsson O,
Romarheim OH, Jacobsen M, Lea T (2013) The noncommensal bacterium Methylococcus
capsulatus (Bath) ameliorates dextran sulfate (sodium salt)-induced ulcerative colitis by
influencing mechanisms essential for maintenance of the colonic barrier function. Appl Environ
Microbiol 79:48–56
Kovaleva J, Degener JE, van der Mei HC (2014) Methylobacterium and its role in health
care-associated infection. J Clin Microbiol 52:1317–1321
Kulakov LA, McAlister MB, Ogden KL, Larkin MJ, O’Hanlon JF (2002) Analysis of bacteria
contaminating ultrapure water in industrial systems. Appl Environ Microbiol 68:1548–1555
Kumar S, Stecher G, Tamura K (2016) MEGA7: Molecular Evolutionary Genetic Analysis version
7.0 for bigger datasets. Mol Biol Evol 33:1870–1874
Lai C-C, Cheng A, Liu W-L, Tan C-K, Huang Y-T, Chung K-P, Lee M-R, Hsueh P-R (2011)
Infections caused by unusual Methylobacterium species. J Clin Microbiol 49:3329–3331
Lauder AP, Roche AM, Sherrill-Mix S, Bailey A, Laughlin AL, Bittinger K, Leite R, Elovitz MA,
Perry A, Bushman FD (2016) Comparison of placenta samples with contamination controls
does not provide evidence for a distinct placenta microbiome. Microbiome 4:29
Lawson LD, Wang ZH, Hughes BG (1991) Identification and HPLC quantitation of the sulfides and
dialk(en)yl thiosulfinates in commercial garlic products. Planta Med 57:363–370
Leach JM, Chung LTK (1982) Gas concentrations and occupational health in Kraft mills.
TAPPI J 65:95–98
Lee C-H, Tang Y-F, Liu J-W (2004) Underdiagnosis of urinary tract infection caused by
Methylobacterium species with current standard processing of urine culture and its clinical
implications. J Med Microbiol 53:755–759
Leonardos G, Kendall D, Barnard N (1969) Odor threshold determination of 53 odorant chemicals.
J Air Pollut Control Assoc 19:91–95
Lindinger W, Taucher J, Jordan A, Hansel A, Vogel W (1997) Endogenous production of methanol
after the consumption of fruit. Alcohol Clin Exp Res 21:939–943
Ljunggren G, Norberg B (1948) On the effect and toxicity of dimethyl-sulphide, dimethyl-
sulphoxide and methyl-mercaptan. Acta Physiol Scand 5:248–255
McFeters GA, Broadaway SC, Pyle BH, Egozy Y (1993) Distribution of bacteria within operating
laboratory water purification systems. Appl Environ Microbiol 59:1410–1415
Mitchell SC, Smith RL (2001) Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos
29:517–521
Moore JG, Jessop LD, Osborne DN (1987) Gas-chromatographic and mass-spectrometric analysis
of the odor of human feces. Gastroenterology 93:1321–1329
Musilova M, Wright G, Ward JM, Dartnell LR (2015) Isolation of radiation-resistant bacteria from
Mars analog Antarctic dry valleys by preselection, and the correlation between radiation and
desiccation resistance. Astrobiology 15:1076–1090
Nešvera J, Pátek M, Hochmannová J, Chibisova E, Sererijski I, Tsyganov T, Netrusov A (1991)
Transformation of a new Gram-positive methylotroph, Brevibacterium methylicum, by plasmid
DNA. Appl Microbiol Biotechnol 35:777–780
Pino A, Giunta G, Randazzo CL, Caruso S, Caggia C, Cianci A (2017) Bacterial biota of women
with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microbial
Ecol Health Dis 28:1357417
Preti G, Huggins GR, Bares J (1978) Analysis of human vaginal secretions by gas chromatography-
mass spectrometry. Isr J Chem 17:215–222
Qiagen (2013) Vaginal flora DNA qPCR array (BAID-1902ZRA) product information leaflet
18 R. Boden
Rutherford PC, Narkowicz JE, Wood JC, Peel MM (1988) Peritonitis caused by Pseudomonas
mesophilica in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol
26:2441–2443
Salter SJ, CoxMJ, Turek EM, Calus ST, CooksonWO,Moffatt MF, Turner P, Parkhill J, Loman NJ,
Walker AW (2014) Reagent and laboratory contamination can critically impact sequence-based
microbiome analyses. BMC Biol 12:87
Sanhueza E, Andreae MO (1991) Emission of formic acid and acetic acids from tropical Savanna
soils. Geophys Res Lett 18:1707–1710
Schäfer H, Myronova N, Boden R (2010) Microbial degradation of dimethylsulphide and related
C1-sulphur compounds: organisms and pathways controlling fluxes of sulphur in the biosphere.
J Exp Bot 61:315–334
Schellenberg JJ, Links MG, Hill JE, Dumonceaux TJ, Kimani J, Jaoko W, Wachihi C, Mungai JN,
Peters GA, Tyler S, Graham M, Severini A, Fowke KR, Ball TB, Plummer FA (2011)
Molecular detection of vaginal microbiota in East African commercial sex workers. Appl
Environ Microbiol 77:4066–4074
Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K (2009) Dimethyl trisulfide as a characteristic
odor associated with fungating cancer wounds. Biosci Biotechnol Biochem 73:2117–2120
Smet E, Lens E, van Langenhove H (1998) Treatment of waste gases contaminated with odorous
sulfur compounds. Crit Rev Environ Sci Technol 28:89–117
Smith TJ, Murrell JC (2011) Mutagenesis of soluble methane monooxygenase. Methods Enzymol
495:135–147
Smith SM, Eng RHK, Forrester C (1985) Pseudomonas mesophilica infections in humans. J Clin
Microbiol 21:314–317
Suarez FL, Springfeld J, Levitt MD (1999) Identification of gases responsible for the odour of
human flatus and evaluation of a device purported to reduce this odour. Gut 43:100–104
Talou T, Gaset A, Delmas M, Kulifaj M, Montant C (1990) Dimethyl sulfide: the secret for black
truffle hunting by animals? Mycol Res 94:277–278
Tamura K, Nei M (1993) Estimation of the number of nucleotide substitutions in the control region
of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10:512–526
Tonzetich J (1973) The uptake and metabolism of 35 S-labeled volatile sulfur compounds by
putrescent saliva. Biochem Med 7:52–60
Truant AL, Gulati R, Giger O, Satishchandran V, Caya JG (1998) Methylobacterium species:
an increasingly important opportunistic pathogen. Lab Med 29:704–710
Turner C, Spanel P, Smith D (2006) A longitudinal study of methanol in the exhaled breath
of healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas
27:637–648
Tymczyna L, Chmielowiec-Korzeniowska A, Drabik A, Skórska C, Sitkowska J, Cholewa G,
Dutkiewicz J (2007) Efficacy of a novel biofilter in hatchery sanitation: II. Removal of
odorogenous pollutants. Ann Agric Environ Med 14:151–157
Usha PR, Naidu MU (2004) Randomised, double-blind, parallel, placebo-controlled study of oral
glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig
24:353–363
Uy MM, Uy J, Castro CZR, Carvajal TM, Ho HT, Lee AC (2013) Pink pigmented facultative
methylotrophic (PPFM) bacteria isolated from the human scale and nasal cavity. Philipp J Syst
Biol 7:13–21
van Langenhove HR, van Wassenhove FA, Coppin JK, van Acker MR, Schamp NM (1982) Gas
chromatography/mass spectrometry identification of organic volatiles contributing to rendering
odors. Environ Sci Technol 16:883–886
Wang H, Altemus J, Niazi F, Green H, Calhoun BC, Sturgis C, Grobmyer SR, Eng C (2017) Breast
tissue, oral and urinary microbiomes in breast cancer. Oncotarget 8:88122–88138
Warnke PH, Terheyden H, Açil Y, Springer IN, Sherry E, Reynolds M, Russo PAJ, Bredee JP,
Podschun R (2003) Tumor smell reduction with antibacterial essential oils. Cancer 100:879–880
Methanotrophy, Methylotrophy, the Human Body, and Disease 19
Waturangi DE, Nicholas CD, Susanto DO, Suhartono MT (2011) Isolation and identification
of methylotrophic bacteria producing methanol dehydrogenase from human feet and mouth.
HAYATI J Biosci 18:11–15
Weon HY, Kim BY, Joa JH, Son JA, Song MH, Kwon SW, Go SJ, Yoon SH (2008)
Methylobacterium iners sp. nov. and Methylobacterium aerolatum sp. nov., isolated from air
samples in Korea. Int J Syst Evol Microbiol 58:93–96
Weyers S, Verstraelen H, Gerris J, Monstrey S, dos Santos Lopes Santiago G, Saerens B,
De Backer E, Claeys G, Vaneechoutte M, Verhelst R (2009) Microflora of the penile skin-
lined neovagina of transsexual women. BMC Microbiol 9:102
Williams MP (1973) Dimethyl sulfide: methodology, precursor kinetics and vegetable production
evaluation. PhD thesis, Perdue University, USA
Wolrath H, Forsum U, Larsson PG, Borén H (2001) Analysis of bacterial vaginosis-related amines
in vaginal fluid by gas chromatography and mass spectrometry. J Clin Microbiol 39:4026–4031
Wood AP, Kelly DP (2010) Skin microbiology, body odor, and methylotrophic bacteria.
In: Timmis KN (ed) Handbook of hydrocarbon and lipid microbiology. Springer, Berlin
Wood AP, Warren FJ, Kelly DP (2010) Methylotrophic bacteria in trimethylaminuria and bacterial
vaginosis. In: Timmis KN (ed) Handbook of hydrocarbon and lipid microbiology. Springer,
Berlin
Xuan C, Shamonki JM, Chung A, DiNome ML, Chung M, Sieling PA, Lee DJ (2016) Microbial
dysbiosis is associated with human breast cancer. PLoS One 9:e83744
Yabuuchi E, Yano I, Oyaizu H, Hashimoto Y, Ezaki T, Yamamoto H (1990) Proposals of
Sphingomonas paucimobilis gen. nov. and comb. nov., Sphingomonas parapaucimobilis
sp. nov., Sphingomonas yanoikuyae sp. nov., Sphingomonas adhaesiva sp. nov., Sphingomonas
capsulata comb. nov., and two genospecies of the genus Sphingomonas. Microbiol Immunol
34:99–199
Yadzi HR, Movafagh A, Fallah F, Shargh SA, Mansouri N, Pour AH, Hashemi M (2016) Evaluation
of Methylobacterium radiotolerance [sic.] and Sphingomonas yanoikuyae in sentinel lymph
nodes of breast cancer cases. Asian Pac J Cancer Prev 17:279–285
20 R. Boden
